Illumina, Inc.
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $202.61
- 52-Week Range
- $112.65 – $309.35
- Market Cap
- $31.75B
- P/E (TTM)
- 36.15
- EPS (TTM)
- 5.81
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 10.15
- PEG Ratio
- 2.58
- Return on Equity
- 32.39%
- Return on Assets
- 8.32%
- Gross Margin
- 67.68%
- Operating Margin
- 19.06%
- Profit Margin
- 19.72%
- Current Ratio
- 2.63
- Debt/Equity
- 0.74
- Total Debt
- $2.31B
- Free Cash Flow
- $859.00M
- Revenue Growth
- 4.20%
- Earnings Growth
- 45.90%
- Enterprise Value
- $32.73B
Market Snapshot
About
Illumina, Inc. is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Illumina's sequencing and array-based solutions serve customers in research centers, academic institutions, government laboratories, and hospitals around the world. The company is a dominant player in the next-generation sequencing market and has enabled breakthroughs in genomics research and precision medicine.